{"id":1553,"date":"2024-06-12T10:18:10","date_gmt":"2024-06-12T02:18:10","guid":{"rendered":"https:\/\/vcro.online\/?p=1553"},"modified":"2024-07-15T15:24:55","modified_gmt":"2024-07-15T07:24:55","slug":"congrats-assistance-in-developing-small-molecule-drugs-for-alzheimer-disease-has-acquired-us-fda-approval-for-phase-i-human-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.vcro.com.tw\/?p=1553","title":{"rendered":"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials"},"content":{"rendered":"\n

VCRO\u2019s professional team assisted our client’s small molecule drug product in submitting a clinical trial application for Alzheimer’s disease to the US FDA.
In June 2024, we received FDA approval to proceed with its Phase I clinical trial, successfully helping our client smoothly enter the Phase I clinical trial stage.
 
To date, VCRO has accumulated experience in 51 projects assisting clients in applying for US FDA IND. We are familiar with FDA interactions, keep abreast of current regulatory requirements, and provide clients with comprehensive strategic planning based on our rich and solid experience, guiding you through every stage of the clinical trial process.<\/p>\n\n\n

\"\"<\/figure>","protected":false},"excerpt":{"rendered":"

VCRO\u2019s professional team assisted our client’s small molecule drug product in submitting a clinical trial application for Alzheimer’s disease to the US FDA.In June 2024, we received FDA approval to proceed with its Phase I clinical trial, successfully helping our client smoothly enter the Phase I clinical trial stage. To date, VCRO has accumulated experience in […]<\/p>\n","protected":false},"author":1,"featured_media":1710,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1553","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vcro-express"],"yoast_head":"\r\nCongrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials - VCRO<\/title>\r\n<meta name=\"description\" content=\"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials VCRO -\" \/>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.vcro.com.tw\/?p=1553\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials - VCRO\" \/>\r\n<meta property=\"og:description\" content=\"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials VCRO -\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.vcro.com.tw\/?p=1553\" \/>\r\n<meta property=\"og:site_name\" content=\"VCRO\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2024-06-12T02:18:10+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2024-07-15T07:24:55+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/06\/77f25eee-dc6c-4781-a40d-f5493bd9ea78.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"author\" content=\"VCRO\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VCRO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1553#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1553\"},\"author\":{\"name\":\"VCRO\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\"},\"headline\":\"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials\",\"datePublished\":\"2024-06-12T02:18:10+00:00\",\"dateModified\":\"2024-07-15T07:24:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1553\"},\"wordCount\":126,\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1553#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/06\/77f25eee-dc6c-4781-a40d-f5493bd9ea78.jpg\",\"articleSection\":[\"VCRO express\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1553\",\"url\":\"https:\/\/www.vcro.com.tw\/?p=1553\",\"name\":\"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials - VCRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1553#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1553#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/06\/77f25eee-dc6c-4781-a40d-f5493bd9ea78.jpg\",\"datePublished\":\"2024-06-12T02:18:10+00:00\",\"dateModified\":\"2024-07-15T07:24:55+00:00\",\"description\":\"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials VCRO -\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1553#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vcro.com.tw\/?p=1553\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1553#primaryimage\",\"url\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/06\/77f25eee-dc6c-4781-a40d-f5493bd9ea78.jpg\",\"contentUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/06\/77f25eee-dc6c-4781-a40d-f5493bd9ea78.jpg\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=1553#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vcro.com.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vcro.com.tw\/#website\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"name\":\"VCRO - Asia Pacific CRO Based in Taiwan\",\"description\":\"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan\",\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"alternateName\":\"VCRO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vcro.com.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\",\"name\":\"Virginia Contract Research Organization Co., Ltd.\",\"alternateName\":\"VCRO\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"contentUrl\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"width\":512,\"height\":512,\"caption\":\"Virginia Contract Research Organization Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\",\"https:\/\/line.me\/R\/ti\/p\/277jsobo\",\"http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\",\"name\":\"VCRO\",\"sameAs\":[\"https:\/\/www.vcro.com.tw\"],\"url\":\"https:\/\/www.vcro.com.tw\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials - VCRO","description":"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials VCRO -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vcro.com.tw\/?p=1553","og_locale":"en_US","og_type":"article","og_title":"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials - VCRO","og_description":"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials VCRO -","og_url":"https:\/\/www.vcro.com.tw\/?p=1553","og_site_name":"VCRO","article_publisher":"https:\/\/www.facebook.com\/people\/\/100057388670681\/","article_published_time":"2024-06-12T02:18:10+00:00","article_modified_time":"2024-07-15T07:24:55+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/06\/77f25eee-dc6c-4781-a40d-f5493bd9ea78.jpg","type":"image\/jpeg"}],"author":"VCRO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VCRO","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vcro.com.tw\/?p=1553#article","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/?p=1553"},"author":{"name":"VCRO","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43"},"headline":"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials","datePublished":"2024-06-12T02:18:10+00:00","dateModified":"2024-07-15T07:24:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1553"},"wordCount":126,"publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=1553#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/06\/77f25eee-dc6c-4781-a40d-f5493bd9ea78.jpg","articleSection":["VCRO express"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vcro.com.tw\/?p=1553","url":"https:\/\/www.vcro.com.tw\/?p=1553","name":"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials - VCRO","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=1553#primaryimage"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=1553#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/06\/77f25eee-dc6c-4781-a40d-f5493bd9ea78.jpg","datePublished":"2024-06-12T02:18:10+00:00","dateModified":"2024-07-15T07:24:55+00:00","description":"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials VCRO -","breadcrumb":{"@id":"https:\/\/www.vcro.com.tw\/?p=1553#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vcro.com.tw\/?p=1553"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/?p=1553#primaryimage","url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/06\/77f25eee-dc6c-4781-a40d-f5493bd9ea78.jpg","contentUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/06\/77f25eee-dc6c-4781-a40d-f5493bd9ea78.jpg","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/www.vcro.com.tw\/?p=1553#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vcro.com.tw\/"},{"@type":"ListItem","position":2,"name":"Congrats! Assistance in developing small molecule drugs for Alzheimer disease has acquired US FDA approval for Phase I human clinical trials"}]},{"@type":"WebSite","@id":"https:\/\/www.vcro.com.tw\/#website","url":"https:\/\/www.vcro.com.tw\/","name":"VCRO - Asia Pacific CRO Based in Taiwan","description":"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan","publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"alternateName":"VCRO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vcro.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vcro.com.tw\/#organization","name":"Virginia Contract Research Organization Co., Ltd.","alternateName":"VCRO","url":"https:\/\/www.vcro.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","contentUrl":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","width":512,"height":512,"caption":"Virginia Contract Research Organization Co., Ltd."},"image":{"@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/\/100057388670681\/","https:\/\/line.me\/R\/ti\/p\/277jsobo","http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr"]},{"@type":"Person","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43","name":"VCRO","sameAs":["https:\/\/www.vcro.com.tw"],"url":"https:\/\/www.vcro.com.tw\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1553"}],"version-history":[{"count":3,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1553\/revisions"}],"predecessor-version":[{"id":1711,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/1553\/revisions\/1711"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/media\/1710"}],"wp:attachment":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}